Tarakji Ahmad M, Morales Fermin, Rovito Peter
Department of Surgery, Lehigh Valley Hospital, Cedar Crest & 1-78, P.O. Box 689, Allentown, PA 18105-1556, USA.
Obes Surg. 2007 Mar;17(3):414-5. doi: 10.1007/s11695-007-9050-1.
After Roux-en-Y gastric bypass (RYGBP), the excluded gastric remnant represents a challenge for the surgeon. Many diseases are reported to take place in that remnant, such as cancer, gastritis, and ulcer. On the other hand, diagnosing these pathological changes requires invasive intervention. We report the use of a noninvasive study to diagnose pathology in the bypassed stomach.